Home / Brands / Avkare Incorporated
Avkare Incorporated Recalls
5 recalls on record · September 12, 2018 to September 12, 2018 · Drugs
Also filed under
The recall feeds record what looks like the same company under more than one name:
September 12, 2018DrugsFDA
Avkare Incorporated recalls AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. P
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
September 12, 2018DrugsFDA
Avkare Incorporated recalls AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
September 12, 2018DrugsFDA
Avkare Incorporated recalls AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc.
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
September 12, 2018DrugsFDA
Avkare Incorporated recalls AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
September 12, 2018DrugsFDA
Avkare Incorporated recalls AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc.
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.